Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
2009; Oxford University Press; Volume: 95; Issue: 1 Linguagem: Inglês
10.1210/jc.2009-1238
ISSN1945-7197
AutoresOlaf M. Dekkers, Joep Lagró, Pia Burman, Jens Otto Lunde Jørgensen, Johannes A. Romijn, Alberto M. Pereira,
Tópico(s)Growth Hormone and Insulin-like Growth Factors
ResumoContext: Dopamine agonists are the treatment of choice for prolactinomas and symptomatic idiopathic hyperprolactinemia. However, the optimal treatment strategy and treatment duration is not clear in all details.
Referência(s)